Movement-activated cortical myoclonus in Dravet syndrome

被引:13
|
作者
Canafoglia, Laura [1 ]
Ragona, Francesca [2 ]
Panzica, Ferruccio [1 ]
Piazza, Elena [2 ]
Freri, Elena [2 ]
Binelli, Simona [1 ]
Scaioli, Vidmer [1 ]
Avanzini, Giuliano [1 ]
Granata, Tiziana [2 ]
Franceschetti, Silvana [1 ]
机构
[1] Fdn IRCCS Ist Neurol Carlo Besta, Neurophysiopathol & Epilepsy Ctr, Milan, Italy
[2] Fdn IRCCS Ist Neurol Carlo Besta, Child Neurol, Milan, Italy
关键词
Dravet syndrome; Cortical myoclonus; Cortico-muscolar coherence; Spectral analysis; Somatosensory evoked potentials; SCN1A mutations; EPILEPSY; INFANTS; CHILDREN;
D O I
10.1016/j.eplepsyres.2017.01.007
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Purpose: we characterized multifocal myoclonus in Dravet syndrome (DS) that was never systematically typified before. Methods: we studied EEG-EMG recordings of 19 consecutive patients, aged 2-29 years, with DS associated with SCN1A gene mutations to detect and evaluate myoclonus based on the spectrum of EMG activity on antagonist muscle pairs and cortico-muscular coherence (CMC). Results: multifocal action myoclonus was detected in all patients corresponding to brief EMG bursts, which occurred synchronously on antagonist muscles at a frequency peaking in beta band. There was significant CMC in beta band, and a cortico-muscular transfer time consistent with a cortical origin of the jerks. The somatosensory evoked potentials (SSEPs) were giant in only one patient who also showed exaggerated long-loop reflexes (LLRs). The nine patients who had experienced myoclonic seizures showed greater CMC. Conclusions: The cortical myoclonus consistently observed in patients with DS shows features that are similar to those characterizing progressive myoclonus epilepsy, but differs because it does not have a severely worsening course and is not commonly associated with increased SSEPs or enhanced LLRs. This kind of myoclonus is an intrinsic feature of DS associated with SCN1A mutations, and may be a cause of disability. Significance: We hypothesize that myoclonus is generated in cortical motor areas by hyper-synchronous oscillations, which are possibly due to sodium channel dysfunction. (C) 2017 Elsevier B.V. All rights reserved.
引用
收藏
页码:47 / 52
页数:6
相关论文
共 50 条
  • [31] Two Perspectives on Dravet Syndrome: Viewpoints from the Clinician and the Caregiver
    Bluvstein, Judith
    Wenniger, Susanna
    NEUROLOGY AND THERAPY, 2023, 12 (02) : 343 - 350
  • [32] The Efficacy of Ketogenic Diet in 60 Chinese Patients With Dravet Syndrome
    Tian, Xiaojuan
    Chen, Jiaoyang
    Zhang, Jing
    Yang, Xiaoling
    Ji, Taoyun
    Zhang, Yao
    Wu, Ye
    Fang, Fang
    Wu, Xiru
    Zhang, Yuehua
    FRONTIERS IN NEUROLOGY, 2019, 10
  • [33] Myoclonic Absence Seizures in Dravet Syndrome
    Myers, Kenneth A.
    Scheffer, Ingrid E.
    PEDIATRIC NEUROLOGY, 2017, 70 : 67 - 69
  • [34] Strength measurements in patients with Dravet Syndrome
    Wyers, Lore
    Verheyen, Karen
    Ceulemans, Berten
    Desloovere, Kaat
    Walle, Patricia Van de
    Hallemans, Ann
    EUROPEAN JOURNAL OF PAEDIATRIC NEUROLOGY, 2021, 35 : 100 - 110
  • [35] The direct and indirect costs of Dravet Syndrome
    Whittington, Melanie D.
    Knupp, Kelly G.
    Vanderveen, Gina
    Kim, Chong
    Gammaitoni, Arnold
    Campbell, Jonathan D.
    EPILEPSY & BEHAVIOR, 2018, 80 : 109 - 113
  • [36] Genetic therapeutic advancements for Dravet Syndrome
    Chilcott, Ellie
    Diaz, Juan Antinao
    Bertram, Cori
    Berti, Margherita
    Karda, Rajvinder
    EPILEPSY & BEHAVIOR, 2022, 132
  • [37] The profile of social communication in Dravet syndrome
    Lana, Borja
    Crespo-Eguilaz, Nerea
    Sanchez-Carpintero, Rocio
    EPILEPSY & BEHAVIOR, 2024, 159
  • [38] A systematic review of adults with Dravet syndrome
    Selvarajah, Arunan
    Zulfiqar-Ali, Quratulain
    Marques, Paula
    Rong, Marlene
    Andrade, Danielle M.
    SEIZURE-EUROPEAN JOURNAL OF EPILEPSY, 2021, 87 : 39 - 45
  • [39] Treating Dravet syndrome: a patent landscape
    Miziak, Barbara
    Czuczwar, Stanislaw J.
    PHARMACEUTICAL PATENT ANALYST, 2021, 10 (05) : 215 - 217
  • [40] Fenfluramine hydrochloride for the treatment of Dravet syndrome
    Dozieres-Puyravel, Blandine
    Auvin, Stephane
    EXPERT OPINION ON ORPHAN DRUGS, 2020, 8 (04): : 121 - 126